chr17-76007123-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001988.4(EVPL):c.6082G>A(p.Val2028Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000035 in 1,485,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001988.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVPL | ENST00000301607.8 | c.6082G>A | p.Val2028Ile | missense_variant | 22/22 | 1 | NM_001988.4 | ENSP00000301607.3 | ||
EVPL | ENST00000586740.1 | c.6148G>A | p.Val2050Ile | missense_variant | 22/22 | 1 | ENSP00000465630.1 | |||
EVPL | ENST00000589231.1 | c.319G>A | p.Val107Ile | missense_variant | 1/2 | 3 | ENSP00000467717.1 | |||
EVPL | ENST00000587569.5 | n.6551G>A | non_coding_transcript_exon_variant | 20/20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 2AN: 168382Hom.: 0 AF XY: 0.0000224 AC XY: 2AN XY: 89278
GnomAD4 exome AF: 0.0000300 AC: 40AN: 1333602Hom.: 0 Cov.: 30 AF XY: 0.0000384 AC XY: 25AN XY: 650520
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2023 | The c.6082G>A (p.V2028I) alteration is located in exon 22 (coding exon 22) of the EVPL gene. This alteration results from a G to A substitution at nucleotide position 6082, causing the valine (V) at amino acid position 2028 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at